Physician profile
Kathryn Ryan
NPI 1689681587
$374.27
in general payments reported to CMS, 2019-2025
9 companies · $43.31 in 2025
The $43.31 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $50.24 · 2021: $11.82 · 2022: $50.24 · 2023: $80.94 · 2024: $36.52 · 2025: $43.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $118.36 | 2019-2022 | |
| Lilly USA, LLC | $90.68 | 2019-2024 | Mounjaro |
| Abbvie INC. | $41.18 | 2023-2024 | Ubrelvy, Qulipta |
| Merz North America, INC. | $32.68 | 2019 | |
| Sumitomo Pharma America, INC. | $22.72 | 2025 | Myfembree |
| Biohaven Pharmaceutical Holding Company LTD. | $22.13 | 2022 | |
| Galderma Laboratories, L.P. | $20.59 | 2025 | |
| Novo Nordisk INC | $14.49 | 2023 | Wegovy |
| Amarin Pharma, INC. | $11.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.